semaglutide and optic neuropathy Smaller NAION Risk with Found in Large Population Recent Meta-Analysis Argues NAION Risk
Description
Approximately 50% of semaglutide users experience significant weight rebound within one year of stopping the medication, according to clinical follow-up data
TRPM4 and TRPM5 are both required for normal signaling in taste receptor cells
TGF- and its profibrotic effects play a significant role in the pathophysiology of UFs (Ciebiera et al., 2017)
Another realized his nausea improved dramatically when he avoided dairy for 48 hours after his Mounjaro dose
Weight loss may slow temporarily, which is normal and expected
